These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 29306436

  • 21. A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide.
    Motabar O, Goldin E, Leister W, Liu K, Southall N, Huang W, Marugan JJ, Sidransky E, Zheng W.
    Anal Bioanal Chem; 2012 Jan; 402(2):731-9. PubMed ID: 22033823
    [Abstract] [Full Text] [Related]

  • 22. Comparing Cyclophellitol N-Alkyl and N-Acyl Cyclophellitol Aziridines as Activity-Based Glycosidase Probes.
    Jiang J, Beenakker TJ, Kallemeijn WW, van der Marel GA, van den Elst H, Codée JD, Aerts JM, Overkleeft HS.
    Chemistry; 2015 Jul 20; 21(30):10861-9. PubMed ID: 26073749
    [Abstract] [Full Text] [Related]

  • 23. Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease.
    Rudensky B, Paz E, Altarescu G, Raveh D, Elstein D, Zimran A.
    Blood Cells Mol Dis; 2003 Jul 20; 30(1):97-9. PubMed ID: 12667991
    [Abstract] [Full Text] [Related]

  • 24. The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts.
    Saito M, Rosenberg A.
    J Biol Chem; 1985 Feb 25; 260(4):2295-300. PubMed ID: 3919000
    [Abstract] [Full Text] [Related]

  • 25. Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis.
    Gaspar P, Kallemeijn WW, Strijland A, Scheij S, Van Eijk M, Aten J, Overkleeft HS, Balreira A, Zunke F, Schwake M, Sá Miranda C, Aerts JM.
    J Lipid Res; 2014 Jan 25; 55(1):138-45. PubMed ID: 24212238
    [Abstract] [Full Text] [Related]

  • 26. HEPES-buffering of bicarbonate-containing culture medium perturbs lysosomal glucocerebrosidase activity.
    van der Lienden MJC, Aten J, Boot RG, van Eijk M, Aerts JMFG, Kuo CL.
    J Cell Biochem; 2022 May 25; 123(5):893-905. PubMed ID: 35312102
    [Abstract] [Full Text] [Related]

  • 27. An in situ study of beta-glucosidase activity in normal and Gaucher fibroblasts with fluorogenic probes.
    Kohen E, Kohen C, Hirschberg JG, Santus R, Grabowski G, Mangel W, Gatt S, Prince J.
    Cell Biochem Funct; 1993 Sep 25; 11(3):167-77. PubMed ID: 8403230
    [Abstract] [Full Text] [Related]

  • 28. Distinguishing the differences in β-glycosylceramidase folds, dynamics, and actions informs therapeutic uses.
    Ben Bdira F, Artola M, Overkleeft HS, Ubbink M, Aerts JMFG.
    J Lipid Res; 2018 Dec 25; 59(12):2262-2276. PubMed ID: 30279220
    [Abstract] [Full Text] [Related]

  • 29. Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases.
    Ferraz MJ, Marques AR, Appelman MD, Verhoek M, Strijland A, Mirzaian M, Scheij S, Ouairy CM, Lahav D, Wisse P, Overkleeft HS, Boot RG, Aerts JM.
    FEBS Lett; 2016 Mar 25; 590(6):716-25. PubMed ID: 26898341
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Chemoenzymatic synthesis of 6-phospho-cyclophellitol as a novel probe of 6-phospho-β-glucosidases.
    Kwan DH, Jin Y, Jiang J, Chen HM, Kötzler MP, Overkleeft HS, Davies GJ, Withers SG.
    FEBS Lett; 2016 Feb 25; 590(4):461-8. PubMed ID: 26790390
    [Abstract] [Full Text] [Related]

  • 32. Synthesis of broad-specificity activity-based probes for exo-β-mannosidases.
    McGregor NGS, Kuo CL, Beenakker TJM, Wong CS, Offen WA, Armstrong Z, Florea BI, Codée JDC, Overkleeft HS, Aerts JMFG, Davies GJ.
    Org Biomol Chem; 2022 Jan 26; 20(4):877-886. PubMed ID: 35015006
    [Abstract] [Full Text] [Related]

  • 33. Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.
    Schueler UH, Kolter T, Kaneski CR, Zirzow GC, Sandhoff K, Brady RO.
    J Inherit Metab Dis; 2004 Jan 26; 27(5):649-58. PubMed ID: 15669681
    [Abstract] [Full Text] [Related]

  • 34. An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease.
    Atrian S, López-Viñas E, Gómez-Puertas P, Chabás A, Vilageliu L, Grinberg D.
    Proteins; 2008 Feb 15; 70(3):882-91. PubMed ID: 17803231
    [Abstract] [Full Text] [Related]

  • 35. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
    Alfonso P, Pampín S, Estrada J, Rodríguez-Rey JC, Giraldo P, Sancho J, Pocoví M.
    Blood Cells Mol Dis; 2005 Feb 15; 35(2):268-76. PubMed ID: 16039881
    [Abstract] [Full Text] [Related]

  • 36. Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease.
    Serra-Vinardell J, Díaz L, Gutiérrez-de Terán H, Sánchez-Ollé G, Bujons J, Michelakakis H, Mavridou I, Aerts JM, Delgado A, Grinberg D, Vilageliu L, Casas J.
    Int J Biochem Cell Biol; 2014 Sep 15; 54():245-54. PubMed ID: 25084554
    [Abstract] [Full Text] [Related]

  • 37. Assay of glucocerebrosidase using a fluorescent analogue of glucocerebroside for the diagnosis of Gaucher disease.
    Midorikawa M, Okada S, Yutaka T, Yabuuchi H, Naoi M, Kiuchi K, Yagi K.
    Biochem Int; 1985 Sep 15; 11(3):327-32. PubMed ID: 4062951
    [Abstract] [Full Text] [Related]

  • 38. Rapid modifications of N-substitution in iminosugars: development of new β-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease.
    Cheng WC, Weng CY, Yun WY, Chang SY, Lin YC, Tsai FJ, Huang FY, Chen YR.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5021-8. PubMed ID: 23880081
    [Abstract] [Full Text] [Related]

  • 39. Chemical inhibition of β-glucocerebrosidase does not affect phagocytosis and early containment of Leishmania by murine macrophages.
    Ribeiro H, Rocha MI, Castro H, Macedo MF.
    Exp Parasitol; 2020 Sep 01; 216():107939. PubMed ID: 32535115
    [Abstract] [Full Text] [Related]

  • 40. Human glucocerebrosidase mediates formation of xylosyl-cholesterol by β-xylosidase and transxylosidase reactions.
    Boer DE, Mirzaian M, Ferraz MJ, Zwiers KC, Baks MV, Hazeu MD, Ottenhoff R, Marques ARA, Meijer R, Roos JCP, Cox TM, Boot RG, Pannu N, Overkleeft HS, Artola M, Aerts JM.
    J Lipid Res; 2021 Sep 01; 62():100018. PubMed ID: 33361282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.